IL-18 blockade prevented the development of MAS in IL-18BP-deficient mice, the whole indicating that excessive IL-18 signaling is associated with severe manifestations of MAS and that endogenous IL-18BP plays a critical role in regulating IL-18–induced systemic responses [42]. The gene discussed is IL18BP; the disease is macrophage activation syndrome.